An Investigation Into the Efficacy of Herpecin L at Reducing the Frequency and Severity of Cold Sores

Focus Consumer Healthcare

Status

Completed

Conditions

Cold Sores

Treatments

Other: Herpecin L

Study type

Interventional

Funder types

Industry

Identifiers

NCT05796635

20274

Details and patient eligibility

About

Focus Consumer Healthcare has developed Herpecin L. Herpecin L combines many different ingredients hypothesized to promote quick healing and symptom reduction from cold sores.

Enrollment

80 patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Male Female between 18-60 years of age.
Must be in good health with no significant chronic conditions and a BMI under 35.
Must experience regular cold sores or fever blisters
Must agree to avoid daily lip balm or another product designed to alleviate their cold sore (e.g., Abreva or other over-the-counter cold sore products).

Exclusion criteria

Suffers from pre-existing conditions that would prevent them from adhering to the protocol including chronic conditions such as oncological or psychiatric disorders.
Anyone with known severe allergic reactions.
Unwilling to follow the study protocol.
Currently pregnant, breastfeeding, or wanting to become pregnant for the duration of the study.